Biologic Factors Predicting Response to Tamoxifen in Patients Registered to SWOG-8228, Ancillary

HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study

G Arpino;SJ Green;DC Allred;D Lew;S Martino;CK Osborne;RM Elledge Clinical Cancer Research 10:5670-5676

ErbB-2 amplification, ErbB-1 expression and tamoxifen response in ER-positive metastatic breast cancer; a SWOG study

G Arpino;S Green;DC Allred;P Ravdin;D Lew;S Martino;CK Osborne;R Elledge Breast Cancer Research and Treatment 76(1):S67(#232)

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR, and pS2 by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group study

RM Elledge;S Greem;R Pugh;DC Allred;GM Clark;J Hill;P Ravdin;S Martino;CK Osborne International Journal of Cancer 89:111-117

HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: A Southwest Oncology Group study.

RM Elledge;S Green;D Ciocca;R Pugh;DC Allred;GM Clark;J Hill;P Ravdin;J O'Sullivan;S Martino;CK Osborne Clinical Cancer Research 4:7-12

Heat shock proteins hsp27 and hsp70: Lack of correlation with response to tamoxifen and clinical course of disease in estrogen receptor-positive metastatic breast cancer: (A Southwest Oncology Group study).

DR Ciocca;S Green;RM Elledge;GM Clark;R Pugh;P Ravdin;D Lew;S Martino;CK Osborne Clinical Cancer Research 5:1263-1266

Heat shock proteins hsp27 and hsp70 are not associated with clinical resistance to tamoxifen in breast cancer: A Southwest Oncology Group study.

D Ciocca;S Green;R Elledge;G Clark;R Pugh;P Ravdin;D Lew;S Martino;CK Osborne Proc of the American Association for Cancer Research 39:229(#1568)

bcl-1, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: A Southwest Oncology Group study.

RM Elledge;S Green;L Howes;GM Clark;M Berardo;DC Allred;R Pugh;D Ciocca;P Ravdin;J O'Sullivan;S Rivkin;S Martino;CK Osborne Journal of Clinical Oncology 15(5):1916-1922

ER and PGR by ligand binding assay compared with ER, PGR and PS2 by IHC in predicting response to tamoxifen in metastatic breast cancer.

RM Elledge;S Green;D Allred;G Clark;P Ravdin;S Martino;CK Osborne Breast Cancer Research and Treatment 46:65(#258)

bcl-2, p53, and response to tamoxifen in er-positive metastatic breast cancer.

R Elledge;S Green;L Howes;M Berardo;DC Allred;D Ciocca;CK Osborne;P Ravdin;J O'Sullivan;G Langone American Society of Clinical Oncology 15:123(#159)